These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26018536)

  • 21. Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillas.
    Gu XX; Sun J; Jin S; Barenkamp SJ; Lim DJ; Robbins JB; Battey J
    Infect Immun; 1997 Nov; 65(11):4488-93. PubMed ID: 9353024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immune response to acute otitis media in children. II. Serum and middle ear fluid antibody in otitis media due to Haemophilus influenza.
    Sloyer JL; Cate CC; Howie VM; Ploussard JH; Johnston RB
    J Infect Dis; 1975 Dec; 132(6):685-8. PubMed ID: 1104722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children.
    Khan MN; Kaur R; Pichichero ME
    FEMS Immunol Med Microbiol; 2012 Aug; 65(3):439-47. PubMed ID: 22463053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx.
    Abe N; Kodama S; Hirano T; Eto M; Suzuki M
    Laryngoscope; 2006 Mar; 116(3):407-12. PubMed ID: 16540899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local application of CpG oligodeoxynucleotide enhances nontypeable Haemophilus influenzae-specific mucosal IgA responses in the middle ear.
    Kodama S; Hirano T; Abe N; Suzuki M
    Acta Otolaryngol; 2007 Aug; 127(8):809-15. PubMed ID: 17762989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal immunization with outer membrane protein P6 and cholera toxin induces specific sinus mucosal immunity and enhances sinus clearance of nontypeable Haemophilus influenzae.
    Sabirov A; Kodama S; Sabirova N; Mogi G; Suzuki M
    Vaccine; 2004 Aug; 22(23-24):3112-21. PubMed ID: 15297063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum and middle ear antibody response in the chinchilla during otitis media with effusion induced by nonviable nontypeable Haemophilus influenzae.
    DeMaria TF; Yamaguchi T; Bakaletz LO; Lim DJ
    J Infect Dis; 1992 Jun; 165 Suppl 1():S196-7. PubMed ID: 1588163
    [No Abstract]   [Full Text] [Related]  

  • 28. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.
    Bertot GM; Becker PD; Guzmán CA; Grinstein S
    J Infect Dis; 2004 Apr; 189(7):1304-12. PubMed ID: 15031801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A single nasal dose of CCL20 chemokine induces dendritic cell recruitment and enhances nontypable Haemophilus influenzae-specific immune responses in the nasal mucosa.
    Kodama S; Abe N; Hirano T; Suzuki M
    Acta Otolaryngol; 2011 Sep; 131(9):989-96. PubMed ID: 21534717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune response to acute otitis media: association between middle ear fluid antibody and the clearing of clinical infection.
    Sloyer JL; Howie VM; Ploussard JH; Schiffman G; Johnston RB
    J Clin Microbiol; 1976 Sep; 4(3):306-8. PubMed ID: 9424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chinchilla model of experimental otitis media for study of nontypable Haemophilus influenzae vaccine efficacy.
    Green BA; Doyle WJ; Cowell JL
    Methods Enzymol; 1994; 235():59-68. PubMed ID: 8057928
    [No Abstract]   [Full Text] [Related]  

  • 32. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
    Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
    Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of nontypeable Haemophilus influenzae endotoxin in the middle and inner ear during experimental otitis media.
    Demaria TF
    Acta Otolaryngol; 1999; 119(5):583-7. PubMed ID: 10478600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasal-associated lymphoid tissue immunity and vaccine development.
    Kodama S; Suzuki M
    Adv Otorhinolaryngol; 2011; 72():110-2. PubMed ID: 21865705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of Toll-like receptor 4 in eliciting acquired immune responses against nontypeable Haemophilus influenzae following intranasal immunization with outer membrane protein.
    Hirano T; Kodama S; Moriyama M; Kawano T; Suzuki M
    Int J Pediatr Otorhinolaryngol; 2009 Dec; 73(12):1657-65. PubMed ID: 19765832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasal vaccination with P6 outer membrane protein and alpha-galactosylceramide induces nontypeable Haemophilus influenzae-specific protective immunity associated with NKT cell activation and dendritic cell expansion in nasopharynx.
    Noda K; Kodama S; Umemoto S; Abe N; Hirano T; Suzuki M
    Vaccine; 2010 Jul; 28(31):5068-74. PubMed ID: 20478344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humanized Anti-DNABII Fab Fragments Plus Ofloxacin Eradicated Biofilms in Experimental Otitis Media.
    Novotny LA; Chiang T; Goodman SD; Elmaraghy CA; Bakaletz LO
    Laryngoscope; 2021 Oct; 131(10):E2698-E2704. PubMed ID: 33666254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of the ascension of NTHi from the nasopharynx to the middle ear coincident with adenovirus-induced compromise in the chinchilla.
    Miyamoto N; Bakaletz LO
    Microb Pathog; 1997 Aug; 23(2):119-26. PubMed ID: 9245624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines.
    Forsgren A; Riesbeck K; Janson H
    Clin Infect Dis; 2008 Mar; 46(5):726-31. PubMed ID: 18230042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity.
    Kurono Y; Yamamoto M; Fujihashi K; Kodama S; Suzuki M; Mogi G; McGhee JR; Kiyono H
    J Infect Dis; 1999 Jul; 180(1):122-32. PubMed ID: 10353870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.